| Carter, Bob S |
Massachusetts General Hospital
United States |
Standardized Molecular Analyses of Glioma EVs |
5R01CA237500-05 |
|
Matthew Young, Ph.D. |
| Castro, Cesar M |
Massachusetts General Hospital
United States |
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach |
5U01CA279858-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Caulin, Carlos |
University Of Arizona
United States |
Genetic Alterations That Confer High Risk to Oral Premalignant Lesions |
5R01CA274857-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Winfred Malone, Ph.D., M.P.H. |
| Caywood, Emi H |
Nemours Children'S Hospital, Delaware
United States |
Nemours NCI Community Oncology Research Program (NCORP) |
5UG1CA189958-11 |
|
Vanessa A. White, M.P.H. |
| Chak, Amitabh |
Case Western Reserve University
United States |
Pathways of Injury and Repair in Barrett's Carcinogenesis |
5P01CA269019-02 |
|
Ellen Richmond, M.S., GNP-BC |
| Chan, Andrew T |
Massachusetts General Hospital
United States |
Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. |
5R01CA257523-04 |
|
Asad Umar, D.V.M., Ph.D. |
| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions |
5U01CA274514-02 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Chan, Andrew T |
Massachusetts General Hospital
United States |
MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors |
1OT2CA297680-01 |
|
Asad Umar, D.V.M., Ph.D. |
| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs |
5U2CCA271895-02 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Chan, Alexandre |
University Of California-Irvine
United States |
Neurotrophic strategy to mitigate chemotherapy-related brain injury |
5R01CA276212-02 |
PAR-21-329 (R01 Clinical Trial Optional) |
John Clifford, Ph.D. |